BioCareSD Builds Depth in Specialty Distribution by Adding VYVGART HYTRULO to Therapies for Generalized Myasthenia Gravis
TEMPE, Ariz. – July 19, 2023 – BioCareSD today announced VYVGART® HYTRULO injection for subcutaneous use in generalized myasthenia gravis (gMG) will join their fast-growing list of specialty products available for distribution. VYVGART HYTRULO is the...